TrialJournal for immunotherapy of cancer2020

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer.

Claire F Friedman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.